Literature DB >> 1614270

Stimulation of melanin synthesis of B16-F10 mouse melanoma cells by bufalin.

L Zhang1, T Yoshida, Y Kuroiwa.   

Abstract

Bufalin, which is one of prominent components of Chinese toad venom, was found to decrease the rate of cell proliferation of mouse melanoma clone B16-F10 cells and a concomitant stimulation of expression of its melanotic phenotype. The effect of bufalin on melanogenesis included stimulation of tyrosinase activity and increase of cellular melanin content. These effects became apparent after 48 hr exposure to 10(-4) M bufalin and increased thereafter. Other cardiotonic steroids, such as cinobufagin and ouabain, at the concentration of 10(-4) M for 6 days, also showed the stimulatory effect on melanin synthesis of B16-F10 cells, but not digitoxigenin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1614270     DOI: 10.1016/0024-3205(92)90213-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Protective effects of tetrahydrocurcumin (THC) on fibroblast and melanoma cell lines in vitro: it's implication for wound healing.

Authors:  Mahendra Kumar Trivedi; Mayank Gangwar; Sambhu Charan Mondal; Snehasis Jana
Journal:  J Food Sci Technol       Date:  2017-02-27       Impact factor: 2.701

2.  Nanoparticle-conjugated animal venom-toxins and their possible therapeutic potential.

Authors:  Archita Biswas; Aparna Gomes; Jayeeta Sengupta; Poulami Datta; Santiswarup Singha; Anjan Kr Dasgupta; Antony Gomes
Journal:  J Venom Res       Date:  2012-10-23

3.  Immunoliposome co-delivery of bufalin and anti-CD40 antibody adjuvant induces synergetic therapeutic efficacy against melanoma.

Authors:  Ying Li; Jiani Yuan; Qian Yang; Wei Cao; Xuanxuan Zhou; Yanhua Xie; Honghai Tu; Ya Zhang; Siwang Wang
Journal:  Int J Nanomedicine       Date:  2014-12-04

4.  Three new cardiac glycosides obtained from the roots of Streblus asper Lour. and their cytotoxic and melanogenesis-inhibitory activities.

Authors:  Dan Miao; Tengqian Zhang; Jian Xu; Congyu Ma; Wenyuan Liu; Takashi Kikuchi; Toshihiro Akihisa; Masahiko Abe; Feng Feng; Jie Zhang
Journal:  RSC Adv       Date:  2018-05-29       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.